share_log

ParaZero Technologies | SC 13G: Statement of acquisition of beneficial ownership by individuals-Medigus Ltd.(20.04%)

ParaZero Technologies | SC 13G:超过5%持股股东披露文件-Medigus Ltd.(20.04%)

SEC announcement ·  02/14 16:07
Moomoo AI 已提取核心信息
On December 31, 2023, Medigus Ltd., an Israeli company, filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a significant stake in ParaZero Technologies Ltd. According to the filing, Medigus Ltd. holds 2,019,153 ordinary shares of ParaZero Technologies, representing 20.04% of the company's issued and outstanding shares. The filing, made under Rule 13d-1(d), indicates that Medigus Ltd. does not seek to change or influence the control of ParaZero Technologies. The shares are held directly by Medigus Ltd., and the beneficial ownership reported reflects a passive investment position. The address of ParaZero Technologies' principal executive offices is listed as 30 Dov Hoz, Kiryat Ono, Israel, while Medigus Ltd.'s principal business office is located at 10 HaNechoshet Street, Tel Aviv, Israel. The filing was signed by Tali Dinar, Chief Financial Officer of Medigus Ltd., on February 14, 2024, certifying the accuracy of the information provided.
On December 31, 2023, Medigus Ltd., an Israeli company, filed a Schedule 13G with the United States Securities and Exchange Commission, disclosing a significant stake in ParaZero Technologies Ltd. According to the filing, Medigus Ltd. holds 2,019,153 ordinary shares of ParaZero Technologies, representing 20.04% of the company's issued and outstanding shares. The filing, made under Rule 13d-1(d), indicates that Medigus Ltd. does not seek to change or influence the control of ParaZero Technologies. The shares are held directly by Medigus Ltd., and the beneficial ownership reported reflects a passive investment position. The address of ParaZero Technologies' principal executive offices is listed as 30 Dov Hoz, Kiryat Ono, Israel, while Medigus Ltd.'s principal business office is located at 10 HaNechoshet Street, Tel Aviv, Israel. The filing was signed by Tali Dinar, Chief Financial Officer of Medigus Ltd., on February 14, 2024, certifying the accuracy of the information provided.
2023年12月31日,以色列公司Medigus Ltd.向美国证券交易委员会提交了附表13G,披露了ParaZero Technologies Ltd.的大量股份。文件显示,Medigus Ltd.持有ParaZero Technologies的2,019,153股普通股,占该公司已发行和流通股份的20.04%。该文件是根据第13d-1(d)条提交的,表明Medigus Ltd.并未寻求改变或影响ParaZero Technologies的控制权。这些股票由Medigus Ltd. 直接持有,报告的受益所有权反映了被动投资头寸。ParaZero Technologies主要行政办公室的地址被列为以色列小野村的Dov Hoz30号,而Medigus Ltd。”其主要业务办公室位于以色列特拉维夫HaneChoshet街10号。该文件由Medigus Ltd.首席财务官塔利·迪纳尔于2024年2月14日签署,证明了所提供信息的准确性。
2023年12月31日,以色列公司Medigus Ltd.向美国证券交易委员会提交了附表13G,披露了ParaZero Technologies Ltd.的大量股份。文件显示,Medigus Ltd.持有ParaZero Technologies的2,019,153股普通股,占该公司已发行和流通股份的20.04%。该文件是根据第13d-1(d)条提交的,表明Medigus Ltd.并未寻求改变或影响ParaZero Technologies的控制权。这些股票由Medigus Ltd. 直接持有,报告的受益所有权反映了被动投资头寸。ParaZero Technologies主要行政办公室的地址被列为以色列小野村的Dov Hoz30号,而Medigus Ltd。”其主要业务办公室位于以色列特拉维夫HaneChoshet街10号。该文件由Medigus Ltd.首席财务官塔利·迪纳尔于2024年2月14日签署,证明了所提供信息的准确性。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息